Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Predictors of disability worsening in clinically isolated syndrome.
Anti-drug antibodies: B-cell Immunity against therapy.
Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study.
Opexa Therapeutics Announces Tcelna™ as New Brand Name for MS Therapy
Leg spasticity and ambulation in multiple sclerosis.
Can the ABILHAND handle manual ability in MS?
Stiffness as a presenting symptom of an odd clinical condition caused by multiple sclerosis and myotonia congenita.
Hypoperfusion and T1-hypointense lesions in white matter in multiple sclerosis.
LSN MS guidelines for the management of multiple sclerosis.
Neural stem cell diversity and proteomics.
[Optic Neuritis.]
Vitamin D insufficiency and chronic diseases: Hype and reality.
Validity of the Dynamic Gait Index in People With Multiple Sclerosis.
Distribution Patterns of 18F-Labelled Fluoromethylcholine in Normal Structures and Tumors of the Head: A PET/MRI Evaluation.
Fine-Tuning S1P Therapeutics.
Muscarinic receptor subtypes as potential targets to modulate oligodendrocyte progenitor survival, proliferation, and differentiation.
Association of circulating follicular helper T cells with disease course of NMO spectrum disorders.
Dimethyl fumarate: a review of its use in patients with relapsing-remitting multiple sclerosis.
Current options for the treatment of optic neuritis.
Preventing brain atrophy should be the gold standard of effective therapy in multiple sclerosis (after the first year of treatment): Commentary.
Increased Concentrations of Glutamate and Glutamine in Normal-Appearing White Matter of Patients with Multiple Sclerosis and Normal MR Imaging Brain Scans.
Incomplete Septal Cirrhosis After High -Dose Methylprednisolone Therapy And Regression Of Liver Injury.
Mast cells and inflammation.
Vitamin D: Health Panacea or false Prophet?
Design of a regulated lentiviral vector for hematopoietic stem cell gene therapy of globoid cell leukodystrophy.
Pages
« first
‹ previous
…
260
261
262
263
264
265
266
267
268
…
next ›
last »